Aceso Life Science Group Limited, commonly referred to as Aceso Group, is a prominent player in the life sciences industry, headquartered in Hong Kong. Founded in 2015, the company has rapidly established itself as a leader in biopharmaceuticals and innovative healthcare solutions, focusing on research and development, manufacturing, and distribution of cutting-edge medical products. With a strong operational presence across Asia and beyond, Aceso Group is dedicated to enhancing patient outcomes through its unique portfolio of core products, which include advanced therapeutics and diagnostic tools. The company’s commitment to quality and innovation has earned it a notable position in the market, recognised for its contributions to improving healthcare standards. Aceso Group continues to drive advancements in life sciences, positioning itself as a trusted partner in the global healthcare landscape.
How does Aceso Life Science Group Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Paper Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Aceso Life Science Group Limited's score of 5 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Aceso Life Science Group Limited, headquartered in Hong Kong (HK), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, Aceso Life Science Group Limited's climate commitments remain unclear. The company may need to develop and communicate its sustainability strategies to align with industry standards and expectations regarding climate action.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aceso Life Science Group Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.